Skip to content

Safety evaluation of excessive intake of yogurt , in adult men and women

Safety evaluation of excessive intake of yogurt , in adult men and women - Safety evaluation of excessive intake of yogurt , in adult men and women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029058
Enrollment
20
Registered
2018-11-18
Start date
2017-09-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Sponsors

TTC Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Subjects aged from 20 to 64 years old (2)Subjects about 10 people with negative for specific IgE(RAST)against house dust and mite. (3)Subjects about 10 people with discomfort of eyes and nose(sneeze, runny nose, nasal) and positive for specific IgE (RAST) against house dust and mite.

Exclusion criteria

Exclusion criteria: (1)Subjects visiting the hospital for discomfort of eyes and nose or medicines affecting the test result (2)Subjects who have history of regular visits of otorhinolaryngology or planned to clinic visits (3)Subjects with acute rhinitis, sinusitis or hypertrophic rhinitis (4)Subjects with bronchial asthma (5)Subjects with allergies to the test food in the study (6)Subjects judged as unsuitable for the study by the investigator for laboratory evidence or cardiopulmonary function (7)Subjects who have a disease requiring regular medication or a history of serious diseases for which medication was required (8)Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (9)Subjects who have participated in other clinical studies (10)Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating (11)Subjects who are judges as unsuitable for the study based on the results of lifestyle questionnaire (12)Subjects who are judged as unsuitable for the study by the investigator for other reason

Design outcomes

Primary

MeasureTime frame
Hematologic test Blood biochemistry test Urine analysis Blood pressure/pulsation Weight/ body mass index Doctor's questions Adverse event Evaluate at points of 2 week and 4 week of ingestion and 2 weeks after the end of ingestion period

Countries

Japan

Contacts

Public ContactChiharu Goto

TTC Co., Ltd. Clinical Research Planning Department

c.goto@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026